Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
grade D 7.5 -2.34% -0.18
ETON closed down 2.34 percent on Thursday, April 18, 2019, on 69 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical ETON trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Crossed Above 50 DMA Bullish -2.34%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.34%
Lower Bollinger Band Touch Weakness -2.34%
20 DMA Resistance Bearish 1.08%
Fell Below 50 DMA Bearish 1.08%

Older signals for ETON ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Medicine Health Pharmaceutical Pain Pharmaceutical Industry In China Pharmaceuticals Policy Pain Management Science And Technology In The People's Republic Of China Ophthalmic Products Allergic Conjunctivitis Liquid Products Parenteral Nutrition Pharmaceutical Product
Is ETON a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.11
52 Week Low 5.7
Average Volume 32,250
200-Day Moving Average 0.0
50-Day Moving Average 7.578
20-Day Moving Average 7.7743
10-Day Moving Average 7.6645
Average True Range 0.3915
ADX 23.1
+DI 8.4089
-DI 20.2293
Chandelier Exit (Long, 3 ATRs ) 6.9255
Chandelier Exit (Short, 3 ATRs ) 8.3045
Upper Bollinger Band 8.1565
Lower Bollinger Band 7.3921
Percent B (%b) 0.14
BandWidth 9.832396
MACD Line -0.0008
MACD Signal Line 0.0576
MACD Histogram -0.0584
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.89
Resistance 3 (R3) 7.87 7.71 7.83
Resistance 2 (R2) 7.71 7.61 7.73 7.80
Resistance 1 (R1) 7.61 7.55 7.66 7.63 7.78
Pivot Point 7.45 7.45 7.48 7.47 7.45
Support 1 (S1) 7.35 7.35 7.40 7.37 7.22
Support 2 (S2) 7.19 7.29 7.21 7.20
Support 3 (S3) 7.09 7.19 7.18
Support 4 (S4) 7.11